Literature DB >> 12495684

Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan.

M-F Lin1, M-L Huang, S-H Lai.   

Abstract

A case-control study was performed to find the risk factors in the acquisition of extended-spectrum beta-lactamase (ESBL) Klebsiella pneumoniae. From 1 May 2001 to 30 September 2001, 422 isolates ofK. pneumoniae identified by the microbiological laboratory in Hsin-Chu hospital were collected, 59 of which were ESBL-producing strains. The prevalence rate was 14% (59/422). There were 43 case patients (ESBL-producing K. pneumoniae) and 86 controls (non-ESBL-producing K. pneumoniae). Tracheostomy, insertion of a Foley catheter, endotracheal tube, nasogastric tube and central venous catheter were found to be risk factors in the acquisition of K. pneumoniae with ESBLs by univariate analysis. Tracheostomy (odds ratio, 5.13; 95% CI, 1.24-21.1;P =0.023) and ceftazidime use (odds ratio, 13.40; 95% CI, 1.21-148.85; P=0.035) remained as risk factors by multivariate analysis with logistic regression. Other anti-pseudomonal agents should be used as empirical therapy to treat possible Pseudomonas aeruginosa infection in order to reduce ceftazidime use and thereby decrease the prevalence of ESBL producing strains of Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12495684     DOI: 10.1053/jhin.2002.1331

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

1.  Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms.

Authors:  Annemarie van 't Veen; Anneke van der Zee; Jolande Nelson; Ben Speelberg; Jan A J W Kluytmans; Anton G M Buiting
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Authors:  Kenneth M Wener; Vered Schechner; Howard S Gold; Sharon B Wright; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

3.  Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamase.

Authors:  Ana Fernández; María José Pereira; José Manuel Suárez; Margarita Poza; Mercedes Treviño; Pilar Villalón; Juan Antonio Sáez-Nieto; Benito José Regueiro; Rosa Villanueva; Germán Bou
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

4.  Risk factors for and outcomes associated with clinical isolates of Escherichia coli and Klebsiella species resistant to extended-spectrum cephalosporins among patients admitted to Canadian hospitals.

Authors:  Marianna Ofner-Agostini; Andrew Simor; Michael Mulvey; Alison McGeer; Zahir Hirji; Melissa McCracken; Denise Gravel; David Boyd; Elizabeth Bryce
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.

Authors:  Faustine Ndugulile; Roland Jureen; Stig Harthug; Willy Urassa; Nina Langeland
Journal:  BMC Infect Dis       Date:  2005-10-15       Impact factor: 3.090

6.  Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria.

Authors:  Samah Meradji; Abouddihaj Barguigua; Khalid Zerouali; Dekhil Mazouz; Houria Chettibi; Naima Elmdaghri; Mohammed Timinouni
Journal:  Antimicrob Resist Infect Control       Date:  2015-06-12       Impact factor: 4.887

7.  Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial Therapy.

Authors:  Oryan Henig; Jason M Pogue; Raymond Cha; Paul E Kilgore; Umar Hayat; Mahmoud Ja'ara; Raza Muhamad Ali; Salman Mahboob; Rahul Pansare; Kathryn Deeds; Bushra Joarder; Hyndavi Kandala; Sorabh Dhar; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2018-09-27       Impact factor: 3.835

8.  Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.

Authors:  Carolyn Sandoval; Stephen D Walter; Allison McGeer; Andrew E Simor; Suzanne F Bradley; Lorraine M Moss; Mark B Loeb
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

9.  Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.

Authors:  Alexandre R Marra; Sérgio B Wey; Adauto Castelo; Ana Cristina Gales; Ruy Guilherme R Cal; José R do Carmo Filho; Michael B Edmond; Carlos Alberto P Pereira
Journal:  BMC Infect Dis       Date:  2006-02-14       Impact factor: 3.090

10.  Distribution of resistance genes encoding ESBLs in Enterobacteriaceae isolated from biological samples in health centers in Ouagadougou, Burkina Faso.

Authors:  Dissinviel S Kpoda; Abraham Ajayi; Marius Somda; Oumar Traore; Nathalie Guessennd; Aboubakar S Ouattara; Lassana Sangare; Alfred S Traore; Mireille Dosso
Journal:  BMC Res Notes       Date:  2018-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.